Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001179110-21-010215
Filing Date
2021-11-17
Accepted
2021-11-17 16:12:48
Documents
2
Period of Report
2021-11-15

Document Format Files

Seq Description Document Type Size
1 FORM 3 - edgar.html 3  
1 FORM 3 - edgar.xml 3 1770
2 POWEROFATTORNEY harrington_smithpoa.txt EX-24.TXT 3513
  Complete submission text file 0001179110-21-010215.txt   6684
Mailing Address 830 WINTER ST WALTHAM MA 02451
Business Address 830 WINTER ST WALTHAM MA 02451 (781)895-0600
ImmunoGen, Inc. (Issuer) CIK: 0000855654 (see all company filings)

EIN.: 042726691 | State of Incorp.: MA | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O IMMUNOGEN, INC. 830 WINTER STREET WALTHAM MA 02451
Business Address
Harrington-Smith Kristen (Reporting) CIK: 0001894310 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-17999 | Film No.: 211420749